"Disability Grief": A patient's allegorical expression of her disability [0.03%]
“残疾哀痛”：一位患者借喻表达自己的残疾体验
Abdorreza Naser Moghadasi
Abdorreza Naser Moghadasi
Seyed Mohammad Baghbanian,Maryam Ghasemi,Somayeh Sheidaei et al.
Seyed Mohammad Baghbanian et al.
Mansooreh Jamshidian-Tehrani,Hadi Z Mehrjardi,Abolfazl Kasaee et al.
Mansooreh Jamshidian-Tehrani et al.
Seyed Amir Hasan Habibi,Alberto Albanese,Antonio E Elia et al.
Seyed Amir Hasan Habibi et al.
Posterior reversible encephalopathy syndrome with spinal cord involvement as the first presentation of lupus nephritis [0.03%]
系统性红斑狼疮肾炎继发子痫的脊髓受累临床表现病例报告
Ali Asghar Okhovat,Siamak Abdi,Farzad Fatehi
Ali Asghar Okhovat
A survey from Turkey and Iran on comparison of risk factors and etiology in ischemic stroke [0.03%]
土耳其和伊朗的缺血性脑卒中危险因素及病因调查比较研究报告
Gulcin Benbir Senel,Ayse Deniz Elmali,Kaveh Mehrvar et al.
Gulcin Benbir Senel et al.
Thrombolytic treatment in stroke mimic, inevitable but fortunately safe: An observational study from Iran [0.03%]
伊朗的观察性研究：卒中模拟溶栓治疗不可避免但幸运的是安全的
Sara Esmaeili,Motahareh Afrakhteh,Maryam Bahadori et al.
Sara Esmaeili et al.
Background: A number of patients with symptoms of acute cerebral ischemia may have other causes called stroke mimics (SM). The prevalence of SM can be as high as 31% in some reports, and these patients are potentially at the risk of intrave...
Fitness to drive in seizure and epilepsy: A protocol for Iranian clinicians [0.03%]
伊朗临床医生的癫痫和发作驾驶能力指南protocols
Nasim Tabrizi
Nasim Tabrizi
Driving restriction is a well-known undesirable consequence of epilepsy and causes significant problems regarding independence and employment for epileptic patients. Many countries all over the world have provided comprehensive protocols in...
Effectiveness and side effects of dimethyl fumarate in multiple sclerosis after 12 months of follow up: An Iranian clinical trial [0.03%]
富马酸二甲酯治疗多发性硬化疗效及副作用的长期（12个月）临床观察：一项伊朗临床试验
Mohsen Foroughipour,Sahar Gazeran
Mohsen Foroughipour
Background: Multiple sclerosis (MS) is a neurologic disorder with a considerable global burden. During the last decades, some pharmaceutical treatments have been approved for patients with MS. Dimethyl fumarate (DMF) is one of these drugs w...
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica [0.03%]
评估多发性硬化和视神经脊髓炎患者的血清葡萄糖-6-磷酸脱氢酶水平
Niloofar Chitsaz,Leila Dehghani,Amir Safi et al.
Niloofar Chitsaz et al.
Background: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are both demyelinating disorders and oxidative stress is suggested to have a role in their pathogenesis. Glucose-6-phosphate dehydrogenase (G6PD) produces nicotinamide adeni...